Search Within

Adrian Marcel Seifert

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (7)
Groups
  1. Department of Pathology and Laboratory Medicine (7)
  2. GSK Faculty (7)
  3. Sloan Kettering Institute Postdocs (7)
  4. Surgery (7)
  5. Tow Center for Developmental Oncology (TCDO) (7)
  6. Developmental Biology Program Faculty (6)

More Groups

People
  1. Cristina Antonescu (7)
  2. Ferdinando Rossi (7)
  3. Ronald DeMatteo (7)
  4. Shan Zeng (7)
  5. Peter Besmer (6)
  6. Megan Crawley (5)

More People

Years
  1. 2020 (1)
  2. 2018 (1)
  3. 2017 (2)
  4. 2015 (1)
  5. 2014 (1)
  6. 2013 (1)
Publications
  1. Clinical Cancer Research (2)
  2. Cancer Immunology Research (1)
  3. Cancer Research (1)
  4. Journal of Experimental Medicine (1)
  5. Molecular Cancer Therapeutics (1)
  6. Oncogene (1)
Publishers
  1. American Association for Cancer Research (5)
  2. Nature Publishing Group (1)
  3. Rockefeller University Press (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The V654A second-site KIT mutation increases tumor oncogenesis and STAT activation in a mouse model of gastrointestinal stromal tumor
    Journal Article

    Zhang, J. Q.; Bosbach, B.; Loo, J. K.; Vitiello, G. A.; Zeng, S.; Seifert, A. M.; Medina, B. D.; Param, N. J.; Maltbaek, J. H.; Rossi, F.; more...
    Oncogene (2020)

    Fulltext@MSK | Save
  • Macrophages and CD8(+) T cells mediate the antitumor efficacy of combined CD40 ligation and imatinib therapy in gastrointestinal stromal tumors
    Journal Article

    Zhang, J. Q.; Zeng, S.; Vitiello, G. A.; Seifert, A. M.; Medina, B. D.; Beckman, M. J.; Loo, J. K.; Santamaria-Barria, J.; Maltbaek, J. H.; Param, N. J.; more...
    Cancer Immunology Research (2018)

    Fulltext@MSK | Save
  • Wnt/β-catenin signaling contributes to tumor malignancy and is targetable in gastrointestinal stromal tumor
    Journal Article

    Zeng, S.; Seifert, A. M.; Zhang, J. Q.; Cavnar, M. J.; Kim, T. S.; Balachandran, V. P.; Santamaria-Barria, J. A.; Cohen, N. A.; Beckman, M. J.; Medina, B. D.; more...
    Molecular Cancer Therapeutics (2017)

    Fulltext@MSK | Save
  • PD-1/PD-L1 blockade enhances T-cell activity and antitumor efficacy of imatinib in gastrointestinal stromal tumors
    Journal Article

    Seifert, A. M.; Zeng, S.; Zhang, J. Q.; Kim, T. S.; Cohen, N. A.; Beckman, M. J.; Medina, B. D.; Maltbaek, J. H.; Loo, J. K.; Crawley, M. H.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Pharmacological inhibition of KIT activates MET signaling in gastrointestinal stromal tumors
    Journal Article

    Cohen, N. A.; Zeng, S.; Seifert, A. M.; Kim, T. S.; Sorenson, E. C.; Greer, J. B.; Beckman, M. J.; Santamaria-Barria, J. A.; Crawley, M. H.; Green, B. L.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Increased KIT inhibition enhances therapeutic efficacy in gastrointestinal stromal tumor
    Journal Article

    Kim, T. S.; Cavnar, M. J.; Cohen, N. A.; Sorenson, E. C.; Greer, J. B.; Seifert, A. M.; Crawley, M. H.; Green, B. L.; Popow, R.; Pillarsetty, N.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • KIT oncogene inhibition drives intratumoral macrophage M2 polarization
    Journal Article

    Cavnar, M. J.; Zeng, S.; Kim, T. S.; Sorenson, E. C.; Ocuin, L. M.; Balachandran, V. P.; Seifert, A. M.; Greer, J. B.; Popow, R.; Crawley, M. H.; more...
    Journal of Experimental Medicine (2013)

    Fulltext@MSK | Save